 | Up a level |
Daneshvar Ghorbani, Keivan; Bergmann, Frank; Kauczor, Hans-Ulrich; Büchler, Markus W.; Grenacher, Lars (2022). Intrapancreatic accessory spleen: Findings on MR imaging and CT. Surgery open digestive advance, 5, p. 100037. Elsevier 10.1016/j.soda.2021.100037
Schilling, Martin K.; Eichenberger, Martin; Maurer, Christoph A.; Greiner, Richard; Zbären, Peter; Büchler, Markus W. (2002). Long-term survival of patients with stage IV hypopharyngeal cancer: Impact of fundus rotation gastroplasty. World journal of surgery, 26(5), pp. 561-565. Springer-Verlag 10.1007/s00268-001-0268-0
Schmied, Bruno M.; Z'Graggen, Kaspar; Redaelli, Claudio A.; Büchler, Markus W. (2000). Pancreatic and hepatobiliary cancers: Problems in staging of pancreatic and hepatobiliary tumours. Annals of oncology, 11(suppl 3), pp. 161-164. Oxford University Press 10.1093/annonc/11.suppl_3.161
Kollmar, Otto; Schilling, Martin K.; Büchler, Markus W. (2000). Treatment of chyloperitoneum after extended lymphatic dissection during duodenopancreatectomy. International journal of pancreatology, 27(1), pp. 83-88. Humana Press 10.1385/IJGC:27:1:83
Läuffer, Jörg M.; Baer, Hans U.; Maurer, Christoph A.; Wagner, Markus; Zimmermann, Arthur; Büchler, Markus W. (1999). Intrapancreatic accessory spleen. International journal of pancreatology, 25(1), pp. 65-68. Humana Press 10.1385/IJGC:25:1:65
Friess, Helmut; Kleeff, Jörg; Malfertheiner, Peter; Müller, Michael W.; Homuth, Kaiken; Büchler, Markus W. (1998). Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers. International journal of pancreatology, 23(2), pp. 115-124. Humana Press 10.1385/IJGC:23:2:115
Maurer, Christoph A.; Borner, Markus M.; Läuffer, Jörg; Friess, Helmut; Z'Graggen, Kaspar; Triller, Jürgen; Büchler, Markus W. (1998). Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer. International journal of pancreatology, 23(3), pp. 181-186. Humana Press 10.1007/BF02788395
Friess, Helmut; Gassmann, Michael; Büchler, Markus W. (1997). Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers. International journal of pancreatology, 21(1), pp. 43-52. Humana Press 10.1007/BF02785919
